Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Measuring Reliability of Spine Mobilization in Low Back Pain

11. maj 2026 opdateret af: University of Kansas Medical Center

This observational study aims to learn how to measure joint motion and tissue response when pressure is applied to the back and examine how the nervous system responds to the applied pressure. This pressure or mobilization technique is a standard care but we currently do not have a method to measure this technique. Through this study, we hope to validate a tool that allows physical therapists to measure the pressure applied during spinal mobilization.

Participants will be asked to:

  • Receive spinal mobilization
  • Participate in pain threshold testing
  • Answer questionnaires

Studieoversigt

Undersøgelsestype

Observationel

Tilmelding (Faktiske)

50

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Kansas
      • Kansas City, Kansas, Forenede Stater, 66103
        • University of Kansas Medical Center

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ja

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

A convenience sample of healthy subjects (faculty and students, n=25) and subjects with chronic low back pain (n=25) will be recruited from the KUMC campus. Subjects will be excluded if they report lumbar bony or joint pathology (i.e. osteoporosis, rheumatoid arthritis), lumbar/sacral deformities (i.e. spondylolisthesis, spina bifida), spinal surgery, have BMI >30, or are pregnant.

Beskrivelse

Inclusion Criteria:

  • Healthy individuals without current or recent history (within 6 months) of low back pain
  • 18-70 years of age
  • BMI between 18.5-29.9
  • Ability to read and understand English
  • For those with chronic low back pain: 1) low back pain more than 3 months and 2) a minimal pain level of 3 on the 0-10 pain numerical rating scale (NRS) in the last 7 days

Exclusion Criteria:

  • Any signs or symptoms of lumbar pathology (as reported by the participant during interview such as low back pain, or lower limb neurological signs)
  • History of any spinal surgery
  • Lumbar/sacral conditions reported by the subject such as spondylolithesis, spina bifida or spinal fracture
  • Bony pathology such as osteoporosis or rheumatoid arthritis as reported by the participant
  • Pregnancy
  • Spine cancer
  • BMI >30
  • Unable to lay on stomach
  • Resting blood pressure more than 160/90 mmHg
  • Currently taking blood thinning medications
  • Uncontrolled diabetes
  • A medical exclusion from having blood pressure taken such as a peripheral neuropathy
  • Low signal to noise ratio fNIRS signal during calibration/setup

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Kohorter og interventioner

Gruppe / kohorte
Intervention / Behandling
Healthy Participants
Spinal mobilization
The application of manual pressure to stiff spinal segments to improve mobility and control pain.
Chronic Low Back Pain Participants
Spinal mobilization
The application of manual pressure to stiff spinal segments to improve mobility and control pain.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Joint displacement as measured by the laboratory methods and from the lumbar mobilization feedback system.
Tidsramme: Change from Baseline (day1) to immediately post-treatment (day 1)
The amount of joint motion for a given grade as measured by the laboratory methods and from the lumbar mobilization feedback system.
Change from Baseline (day1) to immediately post-treatment (day 1)
Applied forces as measured by the laboratory methods and lumbar mobilization feedback system
Tidsramme: Change from Baseline (day1) to immediately post-treatment (day 1)
The magnitude of force produced by the clinician for each grade as measured by the laboratory methods and lumbar mobilization feedback system
Change from Baseline (day1) to immediately post-treatment (day 1)
Tissue resistance as measured by laboratory methods and the lumbar mobilization feedback system
Tidsramme: Change from Baseline (day1) to immediately post-treatment (day 1)
The degree of stiffness of the joint measured as measured by laboratory methods and the lumbar mobilization feedback system
Change from Baseline (day1) to immediately post-treatment (day 1)
Change in muscle activation as measured by electromyography
Tidsramme: Change from Baseline (day1) to immediately post-treatment (day 1)
Differences in recorded electromyography (EMG) activity before and after administration of the intervention
Change from Baseline (day1) to immediately post-treatment (day 1)
Change in pain threshold as measured by quantitative sensory testing.
Tidsramme: Change from Baseline (day1) to immediately post-treatment (day 1)
The following tests will be used to test sensation threshold before and after grade I - IV mobilization/clinician: pressure pain threshold, conditioned pain modulation, and temporal summation.
Change from Baseline (day1) to immediately post-treatment (day 1)
Brain functional connectivity as measured by functional near infrared spectroscopy
Tidsramme: Change from Baseline (day1) to immediately post-treatment (day 1)
Functional near infrared spectroscopy (fNIRS) is a portable, non-invasive, and inexpensive brain imaging method of monitoring cerebral hemodynamic activity.
Change from Baseline (day1) to immediately post-treatment (day 1)

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

2. oktober 2024

Primær færdiggørelse (Faktiske)

2. februar 2025

Studieafslutning (Faktiske)

2. februar 2025

Datoer for studieregistrering

Først indsendt

12. maj 2025

Først indsendt, der opfyldte QC-kriterier

11. maj 2026

Først opslået (Faktiske)

13. maj 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

13. maj 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

11. maj 2026

Sidst verificeret

1. maj 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • STUDY00148661

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner